112 related articles for article (PubMed ID: 21477782)
1. HSP70 decreases receptor-dependent phosphorylation of Smad2 and blocks TGF-β-induced epithelial-mesenchymal transition.
Li Y; Kang X; Wang Q
J Genet Genomics; 2011 Mar; 38(3):111-6. PubMed ID: 21477782
[TBL] [Abstract][Full Text] [Related]
2. Geldanamycin inhibits TGF-beta signaling through induction of Hsp70.
Yun CH; Yoon SY; Nguyen TT; Cho HY; Kim TH; Kim ST; Kim BC; Hong YS; Kim SJ; Lee HJ
Arch Biochem Biophys; 2010 Mar; 495(1):8-13. PubMed ID: 19995547
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
4. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
5. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
7. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
9. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H
Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504
[TBL] [Abstract][Full Text] [Related]
10. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
Lee HS; Kim C; Kim SB; Kim MG; Park D
Biochem Biophys Res Commun; 2010 May; 395(4):553-9. PubMed ID: 20398629
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
12. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability.
Lee KB; Jeon JH; Choi I; Kwon OY; Yu K; You KH
Biochem Biophys Res Commun; 2008 Feb; 366(4):905-9. PubMed ID: 18082619
[TBL] [Abstract][Full Text] [Related]
13. TSC1 activates TGF-β-Smad2/3 signaling in growth arrest and epithelial-to-mesenchymal transition.
Thien A; Prentzell MT; Holzwarth B; Kläsener K; Kuper I; Boehlke C; Sonntag AG; Ruf S; Maerz L; Nitschke R; Grellscheid SN; Reth M; Walz G; Baumeister R; Neumann-Haefelin E; Thedieck K
Dev Cell; 2015 Mar; 32(5):617-30. PubMed ID: 25727005
[TBL] [Abstract][Full Text] [Related]
14. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
Brown KA; Pietenpol JA; Moses HL
J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
[TBL] [Abstract][Full Text] [Related]
15. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
Sengupta S; Jana S; Bhattacharyya A
Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
[TBL] [Abstract][Full Text] [Related]
16. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
17. Differential TGF-{beta} signaling in retinal vascular cells: a role in diabetic retinopathy?
Van Geest RJ; Klaassen I; Vogels IM; Van Noorden CJ; Schlingemann RO
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1857-65. PubMed ID: 19959647
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads.
Schmierer B; Hill CS
Mol Cell Biol; 2005 Nov; 25(22):9845-58. PubMed ID: 16260601
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
20. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.
Wu YY; Peck K; Chang YL; Pan SH; Cheng YF; Lin JC; Yang RB; Hong TM; Yang PC
Oncogene; 2011 Aug; 30(34):3682-93. PubMed ID: 21441952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
